Updated Jul 16, 2026
Murali Ramachandran is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $318.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-11-26 | KAPA | Kairos Pharma, LTD. | A — Grant or award | 152.7K | $0.00 | |
| 2024-11-25 | KAPA | Kairos Pharma, LTD. | P — Open-market purchase | 200 | $1.59 | $318 |
Murali Ramachandran is a corporate insider — currently tracked as VP of Research and Development. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($318) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Murali Ramachandran profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.